Conference Coverage

ED in type 1 diabetes often resolves

Publish date: September 27, 2013

 

AT THE EASD ANNUAL MEETING

Dr. Wessells said that he had no disclosures. The DCCT and EDIC trials were sponsored by the National Institutes of Health

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

FDA expands Abraxane approval to include advanced pancreatic cancer
MDedge Family Medicine
FDA announces classwide label changes to extended-release/long-acting opioids
MDedge Family Medicine
Correlates of excellent type 1 diabetes control found
MDedge Family Medicine
Just over a third of hypertensive kidney patients are at target BP
MDedge Family Medicine
Insulin-triggered hypoglycemia poses less danger
MDedge Family Medicine
TAVR shows large survival benefit in diabetes patients
MDedge Family Medicine
Diabetes: 8 Strategies to put into Practice
MDedge Family Medicine
Diabetes, pro-BNP a bad mix for cardiac health
MDedge Family Medicine
Gestational diabetes linked to sleep apnea
MDedge Family Medicine
After 15 years, UKPDS sulfonylurea-metformin combo shows no mortality bump
MDedge Family Medicine